49 articles
ICIS Europe's weekly roundup covers rising polyethylene margins, Evonik rejecting BASF's €10.3 billion takeover bid, and logistical disruptions from low Rhine water levels affecting chemical trade.
The CW75 index fell 0.98% for the week ending Sept. 29, outperforming broader markets, while Evonik shares surged following reports of a €10.3 billion acquisition bid from BASF.
The RAG Foundation confirmed it could sell its entire 43% stake in Evonik, following competitor BASF's recent takeover interest. Such a divestment requires board approval and would significantly impac
Experts discuss how a potential BASF and Evonik merger could establish an integrated regional leader to compete in the oversupplied global chemical market. Consolidation is highlighted as vital for Eu
Evonik executives report Mexico's chemical sector is recovering from trade-induced slowdowns with sustained investment despite pending USMCA renewals. While record exports signal resilience, access to
Evonik rejected a takeover offer from BASF valued at roughly €22.15 per share, sources say, calling the price too low. BASF had proposed the acquisition earlier in the week.
Evonik rejected BASF's €10.3 billion takeover bid, stating it was too low for formal negotiations or due diligence, per Financial Times reports.
Sources report BASF and Evonik are in discussions regarding a potential merger to consolidate Europe's chemical sector. Speculation drove Evonik shares up 7%, though both companies declined to comment
BASF confirmed exploratory talks to acquire German specialty chemicals firm Evonik from owner RAG-Stiftung, though outcomes remain uncertain. Evonik simultaneously pursues restructuring with plans to
Evonik and shareholder RAG-Stiftung confirmed BASF's non-binding approach for a potential takeover, aiming to strengthen BASF's specialty chemicals portfolio. The move follows market speculation and r
German chemical giant Evonik announced a strengthened growth strategy targeting Asia and Americas, restructuring portfolios toward specialty polymers and biotech while raising 2026 EBITDA guidance to
European chemical giants like Victrex and Evonik stand to gain from surging PEEK demand driven by humanoid robotics, despite facing stiff competition from rapidly expanding Chinese capacity in the pro
Evonik announced a restructuring plan cutting 3,200 jobs and divesting assets to fund growth in healthcare and biotechnology, raising its 2026 EBITDA guidance to €2.0 billion-2.2 billion. It plans to
Evonik broke ground on an €80 million biotech expansion at its Slovak Fermas site to boost pharmaceutical intermediate production via fermentation, scheduled for completion in early 2028.
Evonik announced plans to close its Hamburg and Bitterfeld production sites by 2027, citing structural inefficiencies and cost competitiveness. This move is part of a broader restructuring strategy to
Evonik announced plans to construct a new GMP-compliant LNP drug production facility in Vancouver with over 150 million CAD investment, targeting 2029 completion. The project will triple existing capa
Evonik concluded its fourth 'Growth Unlimited' vocational empowerment program, releasing a talent capability map to address digital and green transformation needs across seven cities.
Evonik will support Neptune Energy's Altmark lithium extraction project in Germany using its Liocel adsorbent technology during Pilot Phase II. The project targets industrial-scale deployment for a re
Evonik reported a 24% year-on-year increase in adjusted EBITDA to €630 million for Q2 2026, raising its full-year outlook to €2–2.2 billion. Growth stemmed from an 11% sales increase and opportunities
Major European chemical firms including BASF and Evonik reported Q2 earnings beating expectations driven by price increases, prompting raised full-year forecasts despite persistent industry production
Major chemical companies like BASF and Evonik upgraded full-year earnings projections following strong Q2 performance, though raw material cost inflation and geopolitical tensions remain significant h
The German Chemical Industry Association (VCI) downgraded its 2026 production forecast by 1.5%, citing a 3% H1 output decline and high energy costs. Major firms like BASF and Evonik are cutting jobs a
Evonik has launched its AEM anion exchange membrane pilot plant in Marl, Germany, supporting 2.5 GW electrolyzer capacity for cost-effective green hydrogen. The DURAION membranes reduce investment cos
Evonik will invest $100 million over five years to modernize its Lafayette, Indiana facility, enhancing API manufacturing capabilities and automation. This strategic move aims to meet growing US deman
The global specialty chemicals market is projected to reach $834.97 billion by 2026, driven by electronic gases. Major players like Evonik show performance recovery while M&A and capacity expansions a
Evonik raised its 2026 full-year adjusted EBITDA guidance to €2–2.2 billion following a Q2 forecast of €600–650 million, up 23% year-over-year. The upgrade stems from higher volumes and prices, though
Evonik completed the sale of its Hanau, Germany API production assets to ProChem Group to optimize its asset portfolio. The move supports Evonik's strategy to concentrate investments on complex delive
Evonik plans 3,200 job cuts while AbbVie acquires Apogee for nearly $11 billion. C&EN also promotes recent reporting on heavy rare earth extraction in Brazil to counter China's monopoly.
Evonik plans to cut 3,200 jobs globally by 2029 and discontinue its unprofitable polyester business due to weak market dynamics and European structural disadvantages. The move aims to enhance efficien
Evonik and Zeopore launched a new isomerization dewaxing catalyst using mesoporous molecular sieves to boost fuel and lubricant efficiency. The technology reduces product loss and carbon emissions, su
ChemBrief